When you call a GLP-1 clinic and ask about semaglutide, you need to ask a follow-up question they may not volunteer: Is it brand-name or compounded? The answer changes the cost, the regulatory status, and potentially the experience.
What Is Compounded Semaglutide?
Compounded semaglutide is a formulation of semaglutide — the same active molecule — prepared by a licensed compounding pharmacy rather than manufactured by Novo Nordisk (the maker of Wegovy and Ozempic). These pharmacies mix the drug to prescription specifications, typically at a fraction of the brand-name price.
Compounding becomes legal for a specific drug when the FDA places it on the drug shortage list. Semaglutide has been on shortage lists since 2022 due to massive demand. The legal status is tied to FDA shortage designation — which can change. If removed from the shortage list, commercial compounding becomes prohibited.
The Real Differences
Cost
Brand-name Wegovy: $1,100–$1,350/month without insurance.
Compounded semaglutide: $150–$350/month through most clinics and telehealth providers.
The cost gap is the primary reason most patients in the US are now on compounded semaglutide rather than brand-name Wegovy.
Regulatory Status
Brand-name Wegovy and Ozempic went through full FDA clinical trials. The exact formulation — dose, excipients, delivery device — is FDA-approved.
Compounded semaglutide uses an FDA-approved active ingredient mixed by a licensed pharmacy. The specific compounded formulation is not FDA-approved — the pharmacy is operating under 503A or 503B compounding regulations. This is legal while shortage designation holds, but it's a different regulatory category.
What Clinics Don't Always Tell You
Some compounded formulations include additives — B12, NAD+, or other compounds — that are not in the brand-name product. Some patients prefer this; others don't want unknown additives. Ask your clinic what exactly is in their compounded formulation and whether it comes from a 503B outsourcing facility (higher regulatory oversight) or a 503A pharmacy (lower oversight, custom individual prescriptions).
Also: compounded semaglutide requires a prescription and physician oversight, same as the brand. If you're sourcing it from a telehealth provider that offers asynchronous consultation (you fill out a form, they rubber-stamp a prescription), you're getting a lower standard of medical supervision than a clinic where a physician reviews your history, bloodwork, and medications for interactions.
Which Should You Choose?
If your insurance covers brand-name Wegovy or Zepbound with minimal out-of-pocket cost, take it. The brand is the gold standard — FDA-reviewed, consistent formulation, auto-injector device that many patients find easier to use.
If insurance doesn't cover it and cost is the barrier to starting treatment, compounded semaglutide is a legitimate medical option — as long as you're getting it through a clinic with real physician oversight, from a 503B outsourcing facility, and you understand the regulatory status may change.
Either way: don't buy compounded semaglutide from a clinic that can't tell you which pharmacy compounds it, what the exact formulation contains, or whether the pharmacist is licensed in your state.